The United Laboratories International Holdings (HK:3933) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The United Laboratories International Holdings has received approval from the China National Medical Products Administration for its Mupirocin Ointment, enhancing its position in the anti-infective market. This broad-spectrum antibiotic is recognized for treating skin infections and is listed in both the National Essential Drug List and the National Medical Insurance Drug List. The company aims to continue its research and development to deliver more value to shareholders.
For further insights into HK:3933 stock, check out TipRanks’ Stock Analysis page.